Anomeric Specificity of 3- O -Methyl-D-Glycopyranose Against Alloxan Diabetes
- 4 April 1975
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 188 (4183) , 70-71
- https://doi.org/10.1126/science.1167978
Abstract
The individual alpha and beta anomers of the nonmetabolized glucose analog 3-O-methyl-D-glucopyranose (3MG) were studied as protective agents against the alloxan toxicity to pancreatic beta cells in an in vivo rat model. The alpha 3MG provides greater protection than either the beta or the equilibrated compound, as indicated by plasma glucose concentrations 24 hours after the experiment. This specificity suggests that the beta cell membrane is extremely stereospecific, and that glucose or 3MG provide protection against alloxan injury directly by an interaction with the cell membrane and not by subsequent metabolism of the protecting compound.Keywords
This publication has 10 references indexed in Scilit:
- Metabolic and insulin-releasing activities of D-glucose anomersNature, 1975
- The effect of glucose anomers upon insulin and glucagon secretionDiabetologia, 1974
- Anomeric Specificity of Glucose-Stimulated Insulin Release: Evidence for a Glucoreceptor?Science, 1974
- Insulin Secretion by Anomers of D-GlucoseScience, 1974
- Beta Cell Protection to Alloxan Necrosis by Anomers of D-GlucoseScience, 1974
- Effect of alloxan on islet tissue permeability: protection and reversal by sugarsAmerican Journal of Physiology-Legacy Content, 1973
- Transport of 3-O-methyl-d-glucose into mammalian pancreatic ?-cellsPflügers Archiv - European Journal of Physiology, 1973
- A threshold distribution hypothesis for packet storage of insulin and its mathematical modelingJournal of Clinical Investigation, 1972
- Studies on Protection Against the Diabetogenic Effect of Alloxan by Glucose.Experimental Biology and Medicine, 1962
- CXXX.—Partially methylated glucoses. Part III. Monomethyl glucoseJournal of the Chemical Society, Transactions, 1914